PATENT CLAIM ANALYSIS

Application Number: 15998710
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "171000"]

Abstract:
The present disclosure relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is an anti-hormonal agent or a pharmaceutically acceptable salt thereof. The present disclosure also relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof, (2) a second agent which is an anti-hormonal agent or a pharmaceutically acceptable salt thereof, and (3) a third agent which is an agent that regulates the PI3K/Akt/mTOR pathway or a pharmaceutically acceptable salt thereof.

Claim (Index 47):
The combination of claim  42 , wherein the agents are sequentially.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 3.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14429367', '15939218', '14717069', '15101540', '14645578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493709180020437
- 35 USC 102 Novelty (BERT): 0.5452864960618855
- Combined Prediction Score: 0.7289624758080279
- Mean Citation Score: 300.642628
- Max Citation Score: 381.3375
- Similarity Product: 206.7985935240984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test